December 25, 2014 8:09 PM ET

Healthcare Providers and Services

Company Overview of Infu-tech, Inc.

Company Overview

Infu-Tech, Inc. provides specialty pharmaceuticals; infusion therapy, such as administration of nutrients, antibiotics, and other medications either intravenously or through feeding tubes; and other medical products to patients in their homes, nursing homes, and subacute care facilities. Through its Web site, Smartmeds.com, it intends to provide health management applications through wireless devices, such as cellular phones, PDA's, and pagers. The company is 52% owned by Kuala Healthcare, Inc., formerly Continental Health Affiliates, Inc. On March 12, 2002, the voluntary petition of Infu-tech, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 b...

374 Starke Road

Carlstadt, NJ 07072

United States

98 Employees

Phone:

201-896-0100

Fax:

201-635-9360

Key Executives for Infu-tech, Inc.

Infu-tech, Inc. does not have any Key Executives recorded.

Infu-tech, Inc. Key Developments

SEC Revokes Registration Of Securities Of Infu-Tech

The registrations of the registered securities of Infu-tech, Inc. have been revoked. The company had repeatedly failed to file required annual and quarterly reports with the Securities and Exchange Commission (SEC). Thus, the company violated a crucial provision of the federal securities laws that requires public corporations to publicly disclose current, accurate financial information so that investors may make informed decisions. The revocations were ordered in an administrative proceeding before an administrative law judge.

SEC Orders Hearing On Registration Suspension Or Revocation Against Infu-tech

On March 5, 2013, the Securities and Exchange Commission (SEC) instituted public administrative proceeding to determine whether to revoke or suspend for a period not exceeding twelve months the registrations of each class of the securities of Infu-tech, Inc. for failure to make required periodic filings with the Commission. In this Order, the Division of Enforcement (Division) alleges that the company is delinquent in its required periodic filings with the Commission. In this proceeding, instituted pursuant to Exchange Act Section 12(j), a hearing will be scheduled before an Administrative Law Judge. At the hearing, the Administrative Law Judge will hear evidence from the Division and the company to determine whether the allegations of the Division contained in the Order, which the Division alleges constitute failures to comply with Exchange Act Section 13(a) and Rules 13a-1 and 13a-13 there under, are true. The Administrative Law Judge in the proceeding will then determine whether the registrations pursuant to Exchange Act Section 12 of each class of the securities of the company should be revoked or suspended for a period not exceeding twelve months. The Commission ordered that the Administrative Law Judge in this proceeding issue an initial decision not later than 120 days from the date of service of the order instituting proceeding.

Similar Private Companies By Industry

Company Name Region
Clearview Surgical Institute United States
Dupont Hospital, LLC United States
The Brooklyn Hospital Center United States
VestraCare United States
The Peer Group, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Infu-tech, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.